The ESR1 Mutations: From Bedside to Bench to Bedside

Hermida-Prado, F; Jeselsohn, R

Jeselsohn, R (corresponding author), Dana Farber Canc Inst, 450 Brookline Ave, Boston, MA 02215 USA.

CANCER RESEARCH, 2021; 81 (3): 537

Abstract

The ESR1 ligand-binding mutations were unveiled a number of years ago and are the most common genetic mechanism of acquired resistance to endocrine tr......

Full Text Link